Growth-inhibitory effects of a Bulnesia sarmienti aqueous extract on A549 Cells in vitro and S180 cells in vivo

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 3, 2009, Pages 492-498

  Mollah, Mohammad Lalmoddin ^a   Kim, Jung Ok ^b   Lee, Gee Dong ^c   Park, Chang Ho ^c   Hong, Joo Heon ^c   Kim, Hak Yoon ^d   Kim, Kil Soo ^a  

^a Kyungpook National University   (South Korea)

^b Daegu Gyeongbuk Institute for Oriental Medicine Industry   (South Korea)

^c Daegu Bio Industry Center   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

A549 cells; Apoptosis; Bulnesia sarmienti; Cytotoxicity; Growth inhibition

Indexed keywords

BULNESIA SARMIENTI EXTRACT; CATECHIN; PLANT EXTRACT; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BULNESIA SARMIENTI; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; FLOW CYTOMETRY; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREE; TUMOR GROWTH;

ANGIOSPERMS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATECHIN; CELL LINE, TUMOR; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; G1 PHASE; HUMANS; MICE; PLANT BARK; PLANT EXTRACTS; TUMOR SUPPRESSOR PROTEIN P53;

BULNESIA SARMIENTI;

EID: 70350694253     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970902810432     Document Type: Article

References (29)

1. Parkin, D.M., Bray, F., Ferlay, J., Pisani, P. Global cancer statistics. CA. Cancer J. Clin. 2005, 55, 74-108.
2. Beadsmoore, C., Screaton, N. Classification, staging and prognosis of lung cancer. Eur. J. Radiol. 2003, 45, 8-17.
3. Bunn, P.J., Vokes, E., Langer, C., Schiller, J. An update on North American randomized studies in non-small cell lung cancer. Semin. Oncol. 1998, 25, 2-10.
4. Gridelli, C., Rossi, A., Maione, P. Treatment of non-small-cell lung cancer: State of the art and development of new biologic agents. Oncogene. 2003, 22, 6629-6638.
5. Kanadaswami, C., Lee, L.T., Lee, P.P. et al. The antitumor activities of flavonoids. In Vivo. 2005, 19, 895-909.
6. Valente, C., Pedro, M., Duarte, A. et al. Bioactive diterpenoids, new jatrophane and two ent-abietanes, and other constituents from euphorbia pubescens. J. Nat. Prod. 2004, 67, 902-904.
7. Vasilev, N.P., Lonkova, I. Cytotoxic activity of extracts from linum cell cultures. Fitoterapia. 2005, 76, 50-53.
8. Lee, K.H. Novel antitumor agents from higher plants. Med. Res. Rev. 1999, 19, 569-596.
9. Okita, K., Sakaida, I., Hino, K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology. 2002, 62 (Suppl. 1), 24-28.
10. Sadava, D., Ahn, J., Zhan, M.; Pang, M.L et al. Effect of four Chinese herbal extracts on drug-sensitive and multidrugresistant small-cell lung carcinoma cells. Cancer Chemother. Pharmacol. 2002, 49 (4), 261-266.
11. Poggio, L., Hunziker, J.H. Nuclear DNA content variation in Bulnesia. J. Heredity. 1986, 77, 43-48.
12. Comas, C.I., Hunziker, J.H. Isozyme variation in Bulnesia retama, B. schickendantzii and B. fokiosa (Zygophyllaceae) PI. Syst. Ecol. 1996, 199, 193-202.
13. Jo, D.H., Min, K.J., Cha, C.G. The antioxidant and antitumor effects of the extract of Bulnesia sarmienti. J. Food Hyg. Safety. 2007, 2, 120-126.
14. Park, C.H., Kim, D.I.K., Shin, E.J.I. et al. Effect of Bulnesia sarmienti ethanol extract on plasma levels of glucose and lipid in streptozotocin induced diabetic rats. Korean J. Food Sci. Technol. 2008, 40, 455-459.
15. Herrman, M., Lorenz, H.M., Voll, R. et al.. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994, 1122, 5506-5507.
16. Hu, H., Ahn, N.S., Yang, X. et al. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int. J. Cancer. 2002, 102 (3), 250-253.
17. Lee, S.M., Li, M.L., Tse, Y.C. et al. Paeoniae radix a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci. 2002, 71 (19), 2267-2277.
18. Qian, B. Clinical effect of anticancer Chinese medicine. Shanghai Translation Publishing House. 1987, 6-7.
19. Huang, K.C. Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells. Life Sci. 2003, 72 (15), 1705-1716.
20. Wang, G. Effect of two saponins extracted from the polygonatum zanlanscianse on the human leukemia (HL-60) cells. Biol. Pharm. Bull. 2001, 24 (2), 159-162.
21. Wu, G. Anticancer activity of Hemsleya amabilis extract. Life Sci. 2002, 71 (18), 2161-2170.
22. Gao, Y.T., Mclaughlin, J.K., Blot, W.J. et al. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer. Inst. 1994, 86, 855-858
23. Jankun, J., Selman, S.H., Swierez, R., Skrzypezak-Jankun, E. Why drinking green tea could prevent cancer. Nature. 1997, 387, 561.
24. Yang, C.S., Wang, Z.Y. Tea and cancer. J. Natl. Cancer Inst. 1993, 85, 1038-1049
25. Brown, J.M., Wouters, B.G. Apoptosis, p53 and tumor cell sensitivity to anti-cancer agents. Cancer Res. 1999, 59, 1391-1399.
26. Wyllie, A.H., Kerr, J.F., Currie, A.R. Cell death: The significance of apoptosis. Int. Rev. Cytol. 1980, 68, 251-306.
27. Carnero, A. Targeting the cell cycle for cancer therapy. Br. J. Cancer. 2002, 87, 129-133.
28. May, P., May, E. Twenty years of p53 research: Structural and functional aspects of the p53 protein. Oncogene. 1999, 18, 7621-7636.
29. Friesen, C., Herr, I., Krammer, P.H., Debatin, K.M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in druginduced apoptosis in leukemia cells. Nat. Med. 1996, 2, 574-577.